A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
- Status
- RECRUITING
- Phase
- PHASE2
Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
- Status
- RECRUITING
- Phase
- NA
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis
- Status
- COMPLETED
- Phase
- NA
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
- Status
- RECRUITING
- Phase
- PHASE3
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
- Status
- RECRUITING
- Phase
- PHASE4
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
- Status
- RECRUITING
- Phase
- PHASE4
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)
- Status
- COMPLETED
- Phase
- N/A
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
- Status
- RECRUITING
- Phase
- PHASE3
Plan Development for Giving Teclistamab in the Outpatient Setting
- Status
- RECRUITING
- Phase
- PHASE4
Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3